
For many diseases, early detection is a highly effective combat strategy. Doctors rely on medical imaging to detect anomalies which indicate diseases. Technologies like X-rays, computed tomography scans and magnetic resonance imaging all support early detection.
But what if signs of disease could be detected even earlier or more accurately? That’s where AI comes into play, promising better diagnoses and treatments for patients.
A JRC study analysed how AI can support healthcare professionals to better analyse medical images to detect diseases earlier, to reduce clinical workload and to improve long-term patient monitoring.
The authors looked into AI-driven innovation in medical imaging through the lenses of real-world implementation in two use cases:
- Lung cancer screening, where complementary AI methods support early detection and longitudinal follow-up of small nodules, enabling doctors to track potentially cancerous nodules over time.
- Cardiovascular disease classification, using models informed by biomechanics to provide more interpretable biomarkers, helping doctors understand physical changes in cardiac tissues.
The report also focuses on trust and usability, showing how advanced hybrid techniques, such as models that combine deep learning with domain knowledge or estimated uncertainty, can improve both reliability and clinical relevance.
Overcoming barriers to AI adoption
To fully harness the potential of AI methods in the EU healthcare sector, JRC scientists have identified key areas that would benefit from further coordination and investment, and provided recommendations for EU-funded projects:
- Improving access to diverse, well-annotated imaging datasets, which are critical for developing robust and generalisable AI tools. European projects and initiatives such as the European Cancer Imaging Initiative, and the European Health Data Space regulation aim to address these needs by enabling cross-border access to imaging data while upholding compliance with the General Data Protection Regulation.
- Reinforcing interoperability and standardisation across data formats, annotation protocols, and model evaluation, so AI models can be integrated across hospitals and regions.
- Prioritising transparency and clinical validation, to support the safe and effective use of AI in real clinical workflows.
- Sustained coordination between research, policy, and clinical domains will be essential to build a cohesive and trustworthy AI ecosystem and to translate innovation into deployment. Projects and initiatives like TEF-Health, AI Factories, ERICs and the proposed EUCAIM EDIC, on the use of AI in healthcare, offer the infrastructure and governance needed to coordinate AI development for medical imaging, validation and deployment across Europe.
In summary, AI in medical imaging holds transformative potential for early diagnosis, personalised treatment, and efficient healthcare delivery.
Yet, the path forward is not purely technical. It requires a broad and integrated strategy: grounded in trust, supported by infrastructure, aligned with regulation, and guided by clinical needs.
Europe’s continued investment in federated infrastructures, regulatory foresight, and human-centered AI design puts it in a strong position to lead in the development of safe, effective and inclusive medical AI solutions.
Related content
- Publication date
- 1 July 2025
- Author
- Joint Research Centre
- JRC portfolios 2025-27



